IRCT20121117011491N3招募中2 期
The survey of the efficacy of new hemostatic polysaccharide powder to control bleeding in acute traumatic patients
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 192
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Accepting and signing the informed consent of the patients' legal guardian to allow the use of the powder produced in controlled conditions for the patient
- •Existence of ulcers with mild to moderate bleeding with stable vital sign
- •Age more than 18 years
- •Liver and Pelvic damage without peritoneal perforation
排除标准
- •Infectious or contaminated wounds with soil or abdominal contents
- •Peritoneal perforation
- •Renal or Liver failure
- •Past medical history of Hypersensitivity (Hospitalization or hypotension due to drug anaphylaxis)
- •Past medical history of Autoimmune or Immunodeficiency disease or disorder
- •Severe Malnutrition
- •Hereditary coagulation disorder or severe coagulation disorders that prevent patients from the operation
- •Gall bladder laceration of rupture
- •uncontrolled shock state
研究者
相似试验
招募中
不适用
Efficacy and safety of a novel hemostatic forceps in endoscopic submucosal dissection for gastric neoplasm: a prospective randomized controlled trialKCT0008165Asan Medical Center266
进行中（未招募）
不适用
Random Evaluation of Patients Who Have Had Laparoscopic Partial NephrectomyKidney CancerNCT04120805University of Chicago178
已完成
不适用
Analysis of Hemostatic Agents Compared to Physiologic HemostasisRhino SinusitisNCT03068728St. Louis University62
进行中（未招募）
不适用
Comparison of new local hemostatic foam (HemoFoam®)and conventional gauze dressing on hemostasis of vascular access site in hemodialysis patientsBleeding control after needle extraction in Hemodialysis patientsHemodialysis patients,Hemostasis,Hemorrhage,Hemostatics,Bandages,Arteriovenous Fistula,Renal Dialysis.TCTR20180625001no60
已完成
不适用
The efficacy of new bipolar hemostatic forceps for endoscopic resectioJPRN-UMIN000024375Center for Research and Development of Minimally Invasive Treatment, Cancer Center, Keio University10